Experts
Supporters
About Mirrors of Medicine
Disease Area
Bladder cancer
Breast cancer
Chronic pain
COVID-19
Lower Urinary Tract Dysfunction
Prostate cancer
Prostate cancer (US version)
Renal Cell Carcinoma
Method
Accreditation
my dashboard
Join
Login
EN
EN
FR
DE
IT
ES
RU
UK
Bladder cancer
Breast cancer
Chronic pain
COVID-19
Lower Urinary Tract Dysfunction
Prostate cancer
Prostate cancer (US version)
Renal Cell Carcinoma
Method
Accreditation
Method
Experts
Supporters
Principles
About Mirrors of Medicine
Contact
Bladder cancer
Initial treatment of MIBC
Editor in chief
Experts & associates
Background & relevance
Last update: 26-04-2023
View the PinPoint cases (
) and get feedback
cT3b cN0 cM0, cisplatin-eligible
cT3b cN0 cM0, cisplatin-ineligible
cT2 cN0 cM0, cisplatin-eligible
cT2 cN2 cM0, cisplatin-eligible
cT2 cN0 cM0, hydronephrosis, cisplatin-eligible
cT2 cN2 cM0, CR after chemotherapy
cT2 cN0 cM0, extensive CIS, cisplatin-eligible
